Bafna Pharmaceuticals Limited
BAFNAPH

Bafna Pharmaceuticals Limited

Pharmaceuticals
Share price
242
Market cap
₹584 Cr
1Y return
144%

A pharmaceutical manufacturer that produces finished drug formulations for both domestic and international markets. Incorporated in 1981, the company operates across multiple therapeutic segments including antibiotics, anti-inflammatory medications, gastrointestinal drugs, and other specialty formulations. The company distinguishes itself through its commitment to quality manufacturing, regulatory compliance across key markets, and a diversified product portfolio serving healthcare providers and patients across regions.

Track the whales in Bafna Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.

Get started
Bafna Pharmaceuticals — investor holdings · WhaleWatch